Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1151-1160 of 1,467) with videos related to

Pageof 147
Sort By:
Joint Bone Spine|June 9, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA TrialsJosef S Smolen, Peter C Taylor, Gerd Burmester, et al.
The American Journal of Clinical Nutrition|October 11, 2021
Assessing the safety of bioactive ingredients in infant formula that affect the immune system: recommendations from an expert panelEmily A Callahan, Talal Chatila, Richard J Deckelbaum, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Journal of Studies on Alcohol and Drugs|April 21, 2007
Between- and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adultsBrett C Haberstick, David Timberlake, Andrew Smolen, et al.
The Journal of Rheumatology|July 17, 2016
Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II StudiesRobin L Thurmond, Andrew Greenspan, Waldemar Radziszewski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2019
Multimodal [<sup>18</sup> F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic MiceSilvia Hayer, Markus Zeilinger, Volker Weiss, et al.
Lancet (London, England)|June 30, 2009
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trialJosef S Smolen, Jonathan Kay, Mittie K Doyle, et al.
Arthritis and Rheumatism|April 29, 2008
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical featuresEsther Jimenez-Boj, Nancy Kedersha, Makiyeh Tohidast-Akrad, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Kaoru Takase-Minegishi, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
Pageof 147

Showing results (1151-1160 of 1,467) with videos related to

Sort By:
Pageof 147
Joint Bone Spine|June 9, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA TrialsJosef S Smolen, Peter C Taylor, Gerd Burmester, et al.
The American Journal of Clinical Nutrition|October 11, 2021
Assessing the safety of bioactive ingredients in infant formula that affect the immune system: recommendations from an expert panelEmily A Callahan, Talal Chatila, Richard J Deckelbaum, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Journal of Studies on Alcohol and Drugs|April 21, 2007
Between- and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adultsBrett C Haberstick, David Timberlake, Andrew Smolen, et al.
The Journal of Rheumatology|July 17, 2016
Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II StudiesRobin L Thurmond, Andrew Greenspan, Waldemar Radziszewski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2019
Multimodal [<sup>18</sup> F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic MiceSilvia Hayer, Markus Zeilinger, Volker Weiss, et al.
Lancet (London, England)|June 30, 2009
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trialJosef S Smolen, Jonathan Kay, Mittie K Doyle, et al.
Arthritis and Rheumatism|April 29, 2008
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical featuresEsther Jimenez-Boj, Nancy Kedersha, Makiyeh Tohidast-Akrad, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Kaoru Takase-Minegishi, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
Pageof 147